BTN2A1 and central nervous system cancer: Although Vγ9Vδ2 T cells derived from human PBMCs demonstrated good cytotoxicity against gliomas that overexpress BTN2A1/BTN3A1, such overexpression occurred in less than 30% of GBM cases.